Fundraising FoxCytatx
1 known investors
Find your way into Cytatx
Sign up to see every warm intro you have to Cytatx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytatx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cyta Therapeutics develops polymer-based nanogel therapeutics (IntelliGels) to treat obesity, NASH, type 2 diabetes, and metabolic disorders. The company's lead program, Cyta-001, is a liver-targeted drug delivery system encapsulating a thyroid hormone receptor agonist for metabolic disease management.
Founders & leadership
BC
Bernadette C. FendrockChief Executive Officer, founder
WS
W. Stephen FaraciChief Scientific Officer, founder
ST
S. ThayumanavanCo-founder
Investors · 1
Frequently asked questions
- What does Cytatx do?
- Cyta Therapeutics develops polymer-based nanogel therapeutics (IntelliGels) to treat obesity, NASH, type 2 diabetes, and metabolic disorders. The company's lead program, Cyta-001, is a liver-targeted drug delivery system encapsulating a thyroid hormone receptor agonist for metabolic disease management.
- Who founded Cytatx?
- Cytatx was founded by Bernadette C. Fendrock, W. Stephen Faraci, S. Thayumanavan.
- Who are Cytatx's investors?
- Cytatx's investors include The Innovation Space.